Women from as far as Asia and Europe rely on the expertise of fertility specialists at New York Fertility Institute for PGS and PGD testing. At their New York City office in Manhattan’s Upper East Side, the skilled medical team offers onsite embryo testing to detect genetic abnormalities and gender selection. If you’re undergoing in-vitro fertilization at an older age or there’s a history of genetic disorders in your family, you may benefit from PGS and PGD testing. Call New York Fertility Institute today to schedule an appointment or request a consultation online.
Preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD) are both screening tools used to detect genetic disorders in an embryo created through in-vitro fertilization (IVF).
During a preimplantation genetic screening, the New York Fertility Institute team checks for normal chromosome numbers or the loss or gain of chromosomal material.
In preimplantation genetic diagnosis, the medical staff screen an embryo for a single gene disorder, such as Fragile X syndrome. PGD is also an effective tool for early gender identification if you are interested in gender selection.
Your New York Fertility Institute doctor can determine if you need either of these screenings based on a variety of factors. Genetic screening is most often used when you:
You may also need these screenings if you have a family history of chromosomal or genetic disorders, such as Down syndrome or birth defects.
Both PGS and PGD testing occurs after the sperm fertilizes the egg and before the doctor implants the resulting embryo into your uterus.
You will first undergo necessary IVF steps, such as injections to stimulate the production of eggs followed by the egg retrieval process. The New York Fertility Institute team assists in the fertilization of the egg with sperm from your partner or a donor. In the onsite lab, the fertilized egg is allowed to divide for 24 hours or more before PGS or PGD testing is done.
At different stages of embryo development, the New York Fertility Institute medical team removes a few cells from the embryo for PGS or PGD testing. This testing process may occur multiple times, depending on your specific situation.
If screenings reveal any abnormalities in an embryo, your New York Fertility Institute provider won’t transfer it to the uterus. Rather, they select only the healthiest embryos for implantation to reduce the likelihood your baby will have a genetic or chromosomal disorder.
To find out if PGS or PGD testing is right for you, call the team at New York Fertility Institute today or request a consultation online now.